2.2. Analysis.
Comparison 2: Efficacy and safety of IVT lampalizumab 6‐ to 8‐weekly versus sham for geographic atrophy (GA), Outcome 2: GA lesion size change at 1 year (mm2)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.